People who have used amphetamines such as benzedrine and dexedrine appear to be at increased risk of developing Parkinson's disease, according to a new study.

Researchers from the Scripps Research Institute have demonstrated the first known compound to show considerable effectiveness in protecting brain cells affected by Parkinson's disease.

Researchers have identified five new genetic variants that are thought to play a role in Parkinson's disease.

A study from Loyola University suggests that neurological disorders like epilepsy and dementia are on the rise, but new therapies could soon be formed with the help of diagnostic tests and stem cell research.

When admitted to a hospital emergency department, elderly patients who suffer from dementia and delirium often do not understand why they are there. They also tend to not understand ER discharge instructions.

Swedish researchers have found that damaged alpha-synuclein proteins can spread in Parkinson's disease similar to an infection model found in conditions like mad cow disease.

Deep brain stimulation has proven beneficial for some treatment-resistant cases of obsessive-compulsive disorder (OCD), depressive disorders and Tourette syndrome.

Patients with Parkinson's disease find it more difficult to gauge and recognize expressions of emotion in other people's faces and voices, according to new research.

The discovery of a small family of molecules could lead to big advances in the treatment of Parkinson's, Alzheimer's and Huntington's diseases. The molecules protect brain cells in these nerve-degenerative diseases.

Harry Potter scribe J.K. Rowling has donated £10 million to the University of Edinburgh to establish the Anne Rowling Regenerative Neurology Clinic.